+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Degenerative Disc Disease Market by Product Type, Treatment, End-Users - Global Forecast 2025-2030- Product Image
Degenerative Disc Disease Market by Product Type, Treatment, End-Users - Global Forecast 2025-2030- Product Image
Sale

Degenerative Disc Disease Market by Product Type, Treatment, End-Users - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 197 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5674961
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Degenerative Disc Disease Market grew from USD 2.02 billion in 2023 to USD 2.17 billion in 2024. It is expected to continue growing at a CAGR of 7.73%, reaching USD 3.41 billion by 2030.

Degenerative Disc Disease (DDD) primarily refers to the gradual wear and tear of spinal discs, which can result in significant pain and mobility issues. The market scope encompasses medical treatments, including pharmaceuticals, surgical interventions, and newer non-invasive procedures aimed at alleviating these effects. The necessity for such solutions arises from the aging global population and increasing prevalence of the condition, necessitating effective management strategies to ensure quality of life. The application scope extends to both hospital settings and outpatient care centers, including physical therapy and chiropractic clinics, while end-users range from geriatric patients to individuals with occupational hazards contributing to spinal wear.

Market growth is significantly influenced by technological advancements in medical imaging and bioengineering, which have contributed to developing better diagnostic and treatment options. Rising healthcare expenditure, along with increased patient awareness and easy access to treatment, further propels this market. Recent opportunities lie in the development of regenerative medicine and biologics, which hold promise in repairing or rejuvenating damaged discs. Investment in robotic-assisted surgeries and minimally invasive techniques also provides avenues for growth. However, challenges such as stringent regulatory approvals, high costs of advanced treatments, and limited insurance coverage hinder market expansion. Regional disparities in healthcare infrastructure further exacerbate these limitations.

Innovation in biomaterials and stem cell therapies offers promising avenues for future research and business expansion. Companies are encouraged to invest in R&D for new drug formulations and delivery systems, which could catalyze market advancement. CBD-infused and other non-conventional pain management therapies are also emerging areas worth exploring. Moreover, partnerships with academic institutions for clinical trials can bridge the gap between experimental and practical applications. The market is highly competitive, with major players focusing on strategic partnerships, mergers, and acquisitions to strengthen their portfolios. Companies should focus on expanding their geographical footprint and leveraging digital marketing strategies to improve accessibility and awareness of their offerings, thus ensuring sustained growth in this dynamic field.

Understanding Market Dynamics in the Degenerative Disc Disease Market

The Degenerative Disc Disease Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Rising occurrences of degenerative disc disorders
    • Increasing preference for non-surgical treatment options
    • Availability of conservative therapies such as physical therapy, and pain relievers
  • Market Restraints
    • High cost of degenerative disc disease surgeries
  • Market Opportunities
    • Technological advancements in degenerative disc disease treatments
    • Introduction of robotic technology in surgical procedures
  • Market Challenges
    • Availability of alternative therapies

Exploring Porter’s Five Forces for the Degenerative Disc Disease Market

Porter’s Five Forces framework further strengthens the insights of the Degenerative Disc Disease Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Degenerative Disc Disease Market

External macro-environmental factors deeply influence the performance of the Degenerative Disc Disease Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Degenerative Disc Disease Market

The Degenerative Disc Disease Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Degenerative Disc Disease Market

The Degenerative Disc Disease Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Degenerative Disc Disease Market

The Degenerative Disc Disease Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Degenerative Disc Disease Market, highlighting leading vendors and their innovative profiles. These include AnGes MG, Inc., B. Braun SE, Biopharm GmbH, Cerapedics Inc., DePuy Synthes by Medical Device Business Services, Inc., Globus Medical Inc., Kolon TissueGene Inc., Lineage Cell Therapeutics, Inc., Medtronic PLC, NLC Ventures Netherlands B.V., Notogen, Inc., Pfizer Inc., Smith & Nephew PLC, Ulrich Medical USA Inc., and Zimmer Biomet Holdings Inc..

Market Segmentation & Coverage

This research report categorizes the Degenerative Disc Disease Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product Type
    • Devices
      • Cervical Spine
      • Lumbar Spine
      • Spinal Fusion
      • Thoracic Spine
    • Drugs
      • Acetaminophen
      • Muscle Relaxants
      • NSAIDs
      • Oral Steroids
  • Treatment
    • Artificial Disc Replacement
    • Cervical Spine
    • Lumbar Spine
    • Spinal Fusion
    • Thoracic Spine
  • End-Users
    • Clinics
    • Hospitals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising occurrences of degenerative disc disorders
5.1.1.2. Increasing preference for non-surgical treatment options
5.1.1.3. Availability of conservative therapies such as physical therapy, and pain relievers
5.1.2. Restraints
5.1.2.1. High cost of degenerative disc disease surgeries
5.1.3. Opportunities
5.1.3.1. Technological advancements in degenerative disc disease treatments
5.1.3.2. Introduction of robotic technology in surgical procedures
5.1.4. Challenges
5.1.4.1. Availability of alternative therapies
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Degenerative Disc Disease Market, by Product Type
6.1. Introduction
6.2. Devices
6.2.1. Cervical Spine
6.2.2. Lumbar Spine
6.2.3. Spinal Fusion
6.2.4. Thoracic Spine
6.3. Drugs
6.3.1. Acetaminophen
6.3.2. Muscle Relaxants
6.3.3. NSAIDs
6.3.4. Oral Steroids
7. Degenerative Disc Disease Market, by Treatment
7.1. Introduction
7.2. Artificial Disc Replacement
7.3. Cervical Spine
7.4. Lumbar Spine
7.5. Spinal Fusion
7.6. Thoracic Spine
8. Degenerative Disc Disease Market, by End-Users
8.1. Introduction
8.2. Clinics
8.3. Hospitals
9. Americas Degenerative Disc Disease Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Degenerative Disc Disease Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Degenerative Disc Disease Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. DEGENERATIVE DISC DISEASE MARKET RESEARCH PROCESS
FIGURE 2. DEGENERATIVE DISC DISEASE MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
FIGURE 9. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
FIGURE 11. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 13. AMERICAS DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. UNITED STATES DEGENERATIVE DISC DISEASE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 15. UNITED STATES DEGENERATIVE DISC DISEASE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. ASIA-PACIFIC DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. DEGENERATIVE DISC DISEASE MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 21. DEGENERATIVE DISC DISEASE MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. DEGENERATIVE DISC DISEASE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. DEGENERATIVE DISC DISEASE MARKET DYNAMICS
TABLE 7. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY CERVICAL SPINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY LUMBAR SPINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY SPINAL FUSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY THORACIC SPINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY ACETAMINOPHEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY MUSCLE RELAXANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY NSAIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY ORAL STEROIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY ARTIFICIAL DISC REPLACEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY CERVICAL SPINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY LUMBAR SPINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY SPINAL FUSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY THORACIC SPINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 38. ARGENTINA DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 39. ARGENTINA DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 40. BRAZIL DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 41. BRAZIL DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 42. BRAZIL DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 43. BRAZIL DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 44. BRAZIL DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 45. CANADA DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 46. CANADA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 47. CANADA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 48. CANADA DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 49. CANADA DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 50. MEXICO DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 51. MEXICO DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 52. MEXICO DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 53. MEXICO DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 54. MEXICO DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES DEGENERATIVE DISC DISEASE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 61. ASIA-PACIFIC DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 62. ASIA-PACIFIC DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 63. ASIA-PACIFIC DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 64. ASIA-PACIFIC DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 65. ASIA-PACIFIC DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 66. ASIA-PACIFIC DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 67. AUSTRALIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 68. AUSTRALIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 69. AUSTRALIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 70. AUSTRALIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 71. AUSTRALIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 72. CHINA DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 73. CHINA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 74. CHINA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 75. CHINA DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 76. CHINA DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 77. INDIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 78. INDIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 79. INDIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 80. INDIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 81. INDIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 82. INDONESIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 83. INDONESIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 84. INDONESIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 85. INDONESIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 86. INDONESIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 87. JAPAN DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 88. JAPAN DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 89. JAPAN DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 90. JAPAN DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 91. JAPAN DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 92. MALAYSIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 93. MALAYSIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 94. MALAYSIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 95. MALAYSIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 96. MALAYSIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 97. PHILIPPINES DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 98. PHILIPPINES DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 99. PHILIPPINES DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 100. PHILIPPINES DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 101. PHILIPPINES DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 102. SINGAPORE DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 103. SINGAPORE DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 104. SINGAPORE DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 105. SINGAPORE DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 106. SINGAPORE DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 107. SOUTH KOREA DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 108. SOUTH KOREA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 109. SOUTH KOREA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 110. SOUTH KOREA DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 111. SOUTH KOREA DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 112. TAIWAN DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 113. TAIWAN DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 114. TAIWAN DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 115. TAIWAN DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 116. TAIWAN DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 117. THAILAND DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 118. THAILAND DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 119. THAILAND DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 120. THAILAND DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 121. THAILAND DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 122. VIETNAM DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 123. VIETNAM DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 124. VIETNAM DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 125. VIETNAM DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 126. VIETNAM DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 133. DENMARK DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 134. DENMARK DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 135. DENMARK DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 136. DENMARK DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 137. DENMARK DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 138. EGYPT DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 139. EGYPT DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 140. EGYPT DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 141. EGYPT DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 142. EGYPT DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 143. FINLAND DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 144. FINLAND DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 145. FINLAND DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 146. FINLAND DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 147. FINLAND DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 148. FRANCE DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 149. FRANCE DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 150. FRANCE DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 151. FRANCE DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 152. FRANCE DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 153. GERMANY DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 154. GERMANY DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 155. GERMANY DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 156. GERMANY DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 157. GERMANY DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 158. ISRAEL DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 159. ISRAEL DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 160. ISRAEL DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 161. ISRAEL DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 162. ISRAEL DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 163. ITALY DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 164. ITALY DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 165. ITALY DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 166. ITALY DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 167. ITALY DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 168. NETHERLANDS DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 169. NETHERLANDS DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 170. NETHERLANDS DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 171. NETHERLANDS DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 172. NETHERLANDS DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 173. NIGERIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 174. NIGERIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 175. NIGERIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 176. NIGERIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 177. NIGERIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 178. NORWAY DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 179. NORWAY DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 180. NORWAY DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 181. NORWAY DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 182. NORWAY DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 183. POLAND DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 184. POLAND DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 185. POLAND DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 186. POLAND DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 187. POLAND DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 188. QATAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 189. QATAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 190. QATAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 191. QATAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 192. QATAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 193. RUSSIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 194. RUSSIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 195. RUSSIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 196. RUSSIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 197. RUSSIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 198. SAUDI ARABIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 199. SAUDI ARABIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 200. SAUDI ARABIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 201. SAUDI ARABIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 202. SAUDI ARABIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 204. SOUTH AFRICA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 205. SOUTH AFRICA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 206. SOUTH AFRICA DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 207. SOUTH AFRICA DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 208. SPAIN DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 209. SPAIN DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 210. SPAIN DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 211. SPAIN DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 212. SPAIN DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 213. SWEDEN DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 214. SWEDEN DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 215. SWEDEN DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 216. SWEDEN DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 217. SWEDEN DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 218. SWITZERLAND DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 219. SWITZERLAND DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 220. SWITZERLAND DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 221. SWITZERLAND DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 222. SWITZERLAND DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 223. TURKEY DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 224. TURKEY DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 225. TURKEY DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 226. TURKEY DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 227. TURKEY DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 231. UNITED ARAB EMIRATES DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 232. UNITED ARAB EMIRATES DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 234. UNITED KINGDOM DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 236. UNITED KINGDOM DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 238. DEGENERATIVE DISC DISEASE MARKET SHARE, BY KEY PLAYER, 2023
TABLE 239. DEGENERATIVE DISC DISEASE MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Degenerative Disc Disease Market, which are profiled in this report, include:
  • AnGes MG, Inc.
  • B. Braun SE
  • Biopharm GmbH
  • Cerapedics Inc.
  • DePuy Synthes by Medical Device Business Services, Inc.
  • Globus Medical Inc.
  • Kolon TissueGene Inc.
  • Lineage Cell Therapeutics, Inc.
  • Medtronic PLC
  • NLC Ventures Netherlands B.V.
  • Notogen, Inc.
  • Pfizer Inc.
  • Smith & Nephew PLC
  • Ulrich Medical USA Inc.
  • Zimmer Biomet Holdings Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages197
PublishedOctober 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 2.17 Billion
Forecasted Market Value ( USD ) by 2030 $ 3.41 Billion
Compound Annual Growth Rate7.7%
Regions CoveredGlobal
No. of Companies Mentioned15

Related Topics

Related Reports

Lumbar Degenerative Disc Disease Market by Treatment, Route of Administration, End-Users - Global Forecast 2025-2030 - Product Image

Lumbar Degenerative Disc Disease Market by Treatment, Route of Administration, End-Users - Global Forecast 2025-2030

  • Report
  • 184 Pages
  • Global
From
Degenerative Disc Disease Treatment Market Report 2024 - Product Image

Degenerative Disc Disease Treatment Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Lumbar Degenerative Disc Disease (DDD) - Market Insight, Epidemiology and Market Forecast - 2034 - Product Image

Lumbar Degenerative Disc Disease (DDD) - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • 200 Pages
  • Global
From
Degenerative Disc Disease Treatment Market By Drugs, By Route of Administration: Global Opportunity Analysis and Industry Forecast, 2023-2032 - Product Image

Degenerative Disc Disease Treatment Market By Drugs, By Route of Administration: Global Opportunity Analysis and Industry Forecast, 2023-2032

  • Report
  • 320 Pages
  • Global
From
Degenerative Disc Disease - Market Insight, Epidemiology and Market Forecast - 2032 - Product Image

Degenerative Disc Disease - Market Insight, Epidemiology and Market Forecast - 2032

  • Report
  • 161 Pages
  • Global
From

About the Degenerative Disc Disease Drug Market

The Degenerative Disc Disease Drug market is a subset of the larger Musculoskeletal Disorders Drugs market. It is composed of drugs used to treat degenerative disc disease, a condition in which the discs between the vertebrae of the spine become damaged and cause pain. These drugs are typically used to reduce inflammation, pain, and stiffness, and to improve mobility. Commonly prescribed drugs include non-steroidal anti-inflammatory drugs (NSAIDs), muscle relaxants, and corticosteroids. In some cases, surgery may be recommended to treat the condition. The Degenerative Disc Disease Drug market is highly competitive, with many companies offering products to treat the condition. Some of the major players in the market include Pfizer, Merck, Novartis, Johnson & Johnson, and AbbVie. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.